Tarceva Found to be Effective in Treating Lung Cancer

Tarceva Found to be Effective in Treating Lung Cancer

Genetech Inc and OSI Pharmaceuticals have announced their drug Tarceva is effective in delaying the advance of lung cancer. Tarceva is a target agent that is currently used as a second line treatment for patients with Non-small cell lung cancer (NSCLC) after they have failed chemotherapy. OSI and Genentec said their drug met its main goal in a primary treatment clinical trial as it stopped the spread of advanced NSCLC significantly longer than placebo.

read more

How Long Will it Take FDA to Act on Public Citizen Avandia Recall Petition?

Last week a petition was filed by Public Citizen calling on the FDA to issue an Avandia recall as a result of serious and life threatening side effects associated with GlaxoSmithKline’s diabetes drug. No official response has been released by the FDA and it is unclear how long it will take the regulatory agency to respond to the petition.

read more

We Are Always At The Risk Of Cancer

Cancer is such a damaging process that parts of our own body grows uncontrollably and harms us severely. We have to understand how and why cancer starts and progresses. Even if we are in best of physical conditions and environment free of any carcinogens and stresses, we will still be at risk of cancer. The very process of staying alive, the metabolism process that goes in our body cells, the process of digestion, growth etc. alone is sufficient risk for this disease.

How Long Will it Take FDA to Act on Public Citizen Avandia Recall Petition?

How Long Will it Take FDA to Act on Public Citizen Avandia Recall Petition?

Last week a petition was filed by Public Citizen calling on the FDA to issue an Avandia recall as a result of serious and life threatening side effects associated with GlaxoSmithKline’s diabetes drug. No official response has been released by the FDA and it is unclear how long it will take the regulatory agency to respond to the petition.

read more

Tarceva Found to be Effective in Treating Lung Cancer

Genetech Inc and OSI Pharmaceuticals have announced their drug Tarceva is effective in delaying the advance of lung cancer. Tarceva is a target agent that is currently used as a second line treatment for patients with Non-small cell lung cancer (NSCLC) after they have failed chemotherapy. OSI and Genentec said their drug met its main goal in a primary treatment clinical trial as it stopped the spread of advanced NSCLC significantly longer than placebo.

read more